R&D strategy – Talk Bio

Actionable Insights Powered by AI

Novo Nordisk Ends Cell Therapy Research Amid Major Restructuring

2 weeks ago talkbio0Tagged cancellations, Cell Therapy, cost-cutting, Diabetes, Novo Nordisk, Obesity, Partnership, R&D strategy, restructuring

Novo Nordisk; cell therapy; restructuring; job cuts; diabetes; cost-cutting; R&D strategy; biotech; obesity; partnership cancellations

GSK’s Strategic Approach to Deal-Making and Expansion Beyond Obesity with GLP-1s

9 months ago talkbio0Tagged deal-making, expansion, GLP-1s, Obesity, pharmaceutical innovation, R&D strategy, SmithKline Beecham, strategic

GSK, GLP-1s, Obesity, Deal-making, Strategic expansion, Pharmaceutical innovation, R&D strategy